Yanming Wang Selected Research

Autoimmune Diseases (Autoimmune Disease)

6/2015	TRIM30α Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING.
5/2015	TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanming Wang Research Topics

Disease

55	Neoplasms (Cancer) 05/2024 - 04/2004
13	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 02/2002
11	Infections 01/2022 - 06/2015
8	Inflammation (Inflammations) 01/2022 - 01/2014
8	Amyloid Plaque 04/2005 - 02/2002
6	Hypoxia (Hypoxemia) 02/2024 - 01/2016
5	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2018
5	Melanoma (Melanoma, Malignant) 11/2018 - 01/2012
4	Multiple Sclerosis 11/2023 - 12/2012
4	Shock 10/2022 - 08/2014
4	Bites and Stings (Sting) 02/2022 - 06/2015
4	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
4	Ischemia 09/2021 - 01/2014
4	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 01/2011
4	Sepsis (Septicemia) 01/2021 - 08/2014
4	Demyelinating Diseases (Demyelinating Disease) 11/2013 - 11/2009
3	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2018
3	Reperfusion Injury 11/2023 - 01/2014
3	Brain Ischemia (Cerebral Ischemia) 11/2023 - 09/2021
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2020
3	Thrombosis (Thrombus) 11/2022 - 05/2013
3	Acute Lung Injury 01/2021 - 02/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 01/2005
3	Bacterial Infections (Bacterial Infection) 11/2010 - 01/2009
2	Triple Negative Breast Neoplasms 05/2024 - 04/2015
2	Mouth Neoplasms (Oral Cancer) 01/2024 - 08/2019
2	Esophageal Squamous Cell Carcinoma 10/2023 - 03/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 09/2021
2	Septic Shock (Toxic Shock Syndrome) 10/2022 - 08/2014
2	COVID-19 01/2022 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2021 - 07/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2010
2	Cognitive Dysfunction 01/2020 - 01/2019
2	Leukemia 09/2019 - 12/2016
2	Hemorrhage 01/2019 - 02/2016
2	Hemorrhagic Shock 01/2017 - 02/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 11/2013
2	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 05/2015

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2008
11	Histones (Histone)IBA 01/2023 - 08/2010
10	Protein-Arginine DeiminasesIBA 11/2023 - 07/2012
10	Amyloid (Amyloid Fibrils)IBA 04/2007 - 02/2002
7	Peptides (Polypeptides)IBA 10/2023 - 12/2010
7	YW3-56IBA 10/2022 - 07/2012
7	ChromatinIBA 01/2020 - 01/2009
6	PolymersIBA 01/2023 - 01/2019
6	Deoxyribonuclease I (Nickase)IBA 02/2022 - 08/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2015
5	EnzymesIBA 11/2022 - 07/2012
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2009
5	LipopolysaccharidesIBA 01/2022 - 08/2014
5	CytokinesIBA 01/2022 - 06/2014
5	isoliquiritigenin (GU 17)IBA 04/2021 - 01/2012
4	Histone Deacetylase InhibitorsIBA 05/2024 - 07/2012
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 08/2017
4	AntigensIBA 08/2017 - 04/2008
3	LipidsIBA 02/2023 - 01/2011
3	ProdrugsIBA 01/2022 - 12/2020
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2017
3	GoldIBA 01/2021 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 01/2014
2	Carbolines (Beta-Carbolines)IBA 05/2024 - 10/2023
2	Histone Deacetylases (Histone Deacetylase)IBA 05/2024 - 08/2014
2	AlkaloidsIBA 10/2023 - 06/2021
2	Vorinostat FDA Link 01/2023 - 08/2014
2	Neuroprotective AgentsIBA 01/2023 - 04/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2018
2	arginine deiminaseIBA 11/2022 - 08/2015
2	Mitochondrial DNA (mtDNA)IBA 02/2022 - 01/2022
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 08/2015
2	N-methyl-4,4'-diaminostilbeneIBA 01/2022 - 11/2013
2	AntibodiesIBA 01/2022 - 03/2020
2	VaccinesIBA 01/2022 - 01/2022
2	MethyltransferasesIBA 01/2022 - 07/2008
2	Oxygen (Dioxygen)IBA 09/2021 - 01/2020
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2021 - 07/2017
2	MicellesIBA 01/2021 - 05/2018
2	PlatinumIBA 01/2021 - 12/2020
2	Therapeutic UsesIBA 01/2021 - 01/2016
2	FlavonoidsIBA 09/2020 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 03/2017
2	Arginine (L-Arginine)FDA Link 01/2019 - 01/2018
2	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2019 - 08/2014
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 01/2014
2	C-Reactive ProteinIBA 08/2015 - 01/2014

Therapy/Procedure

28	Therapeutics 05/2024 - 09/2002
7	Drug Therapy (Chemotherapy) 11/2022 - 11/2010
4	Lasers (Laser) 01/2021 - 07/2014
3	Photochemotherapy (Photodynamic Therapy) 01/2020 - 03/2017
2	Immunotherapy 02/2024 - 01/2017
2	Castration 01/2023 - 01/2021
2	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2012
2	Radiotherapy 01/2020 - 01/2014
2	Ligation 03/2015 - 08/2014
2	Punctures 03/2015 - 08/2014